Semax

Advanced nootropic peptide for cognitive enhancement and neuroprotection research. ACTH-derived heptapeptide with potent BDNF modulation capabilities.

Semax is a synthetic heptapeptide derived from the 4-10 amino acid fragment of Adrenocorticotropic Hormone (ACTH) (Met-Glu-His-Phe-Pro-Gly-Pro). Through structural optimization, Semax significantly enhances neuroprotective, cognitive-enhancing, and neuromodulatory activities while eliminating the hormonal side effects of native ACTH. By modulating Brain-Derived Neurotrophic Factor (BDNF) expression, optimizing brain monoamine neurotransmitter levels, and promoting cerebral cortical blood perfusion, Semax demonstrates broad application prospects in improving focus, enhancing memory consolidation and retrieval, and accelerating cognitive recovery under high-pressure environments. It is an actively sought-after peptide raw material in the cognitive health and neurological function support sectors.

CAS 80714-61-0
Molecular Formula C₃₇H₅₁N₉O₁₁S
Molecular Weight 813.92 g/mol
Category Nootropic & Neuroprotective Peptides
Purity >=99% (HPLC)
Status Research-grade, analytical verified
Applications Cognitive research, neuroprotection studies, BDNF modulation, stroke recovery

 

CAS

80714-61-0

Applications

, , ,

Leave a message